NASDAQ:CERN - Cerner Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $63.82 -0.49 (-0.76 %) (As of 09/21/2018 04:00 PM ET)Previous Close$64.31Today's Range$63.76 - $64.9752-Week Range$52.05 - $73.86Volume5.27 million shsAverage Volume2.26 million shsMarket Capitalization$21.05 billionP/E Ratio29.04Dividend YieldN/ABeta0.97 Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a cloud-based platform that enables organizations to aggregate, transform, and reconcile data across the continuum of care, as well as EHR agnostic platform, CareAware, that facilitates connectivity of health care devices to EHRs. In addition, the company offers a portfolio of clinical and financial health care information technology solutions, as well as departmental, connectivity, population health, and care coordination solutions; and various complementary services, including support, hosting, managed, implementation, and strategic consulting services. Further, it provides various services, such as implementation and training, remote hosting, operational management, revenue cycle, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third party administrator services for employer-based health plans; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri. Receive CERN News and Ratings via Email Sign-up to receive the latest news and ratings for CERN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Computer integrated systems design Sub-IndustryHealth Care Technology SectorMedical SymbolNASDAQ:CERN CUSIP15678210 Webwww.cerner.com Phone816-221-1024 Debt Debt-to-Equity Ratio0.09 Current Ratio2.85 Quick Ratio2.83 Price-To-Earnings Trailing P/E Ratio29.04 Forward P/E Ratio27.99 P/E Growth2.03 Sales & Book Value Annual Sales$5.14 billion Price / Sales4.08 Cash Flow$3.9714 per share Price / Cash16.07 Book Value$14.40 per share Price / Book4.43 Profitability EPS (Most Recent Fiscal Year)$2.20 Net Income$866.97 million Net Margins16.06% Return on Equity15.26% Return on Assets11.34% Miscellaneous Employees26,000 Outstanding Shares329,000,000Market Cap$21.05 billion Cerner (NASDAQ:CERN) Frequently Asked Questions What is Cerner's stock symbol? Cerner trades on the NASDAQ under the ticker symbol "CERN." How will Cerner's stock buyback program work? Cerner announced that its board has initiated a share buyback plan on Sunday, June 4th 2017, which authorizes the company to buyback $500,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 2.3% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's management believes its shares are undervalued. How were Cerner's earnings last quarter? Cerner Co. (NASDAQ:CERN) issued its quarterly earnings results on Thursday, August, 2nd. The company reported $0.62 earnings per share for the quarter, topping analysts' consensus estimates of $0.60 by $0.02. The company had revenue of $1.37 billion for the quarter, compared to analysts' expectations of $1.33 billion. Cerner had a net margin of 16.06% and a return on equity of 15.26%. The business's quarterly revenue was up 5.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.61 earnings per share. View Cerner's Earnings History. When is Cerner's next earnings date? Cerner is scheduled to release their next quarterly earnings announcement on Thursday, October, 25th 2018. View Earnings Estimates for Cerner. What guidance has Cerner issued on next quarter's earnings? Cerner issued an update on its FY18 earnings guidance on Thursday, August, 2nd. The company provided earnings per share guidance of $2.45-2.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.50. The company issued revenue guidance of $5.325-5.450 billion, compared to the consensus revenue estimate of $5.37 billion.Cerner also updated its Q3 guidance to $0.62-0.64 EPS. What price target have analysts set for CERN? 18 analysts have issued 1-year price targets for Cerner's shares. Their forecasts range from $64.65 to $80.00. On average, they anticipate Cerner's stock price to reach $71.7607 in the next year. This suggests a possible upside of 12.4% from the stock's current price. View Analyst Price Targets for Cerner. What is the consensus analysts' recommendation for Cerner? 18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cerner in the last year. There are currently 7 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cerner. What are Wall Street analysts saying about Cerner stock? Here are some recent quotes from research analysts about Cerner stock: 1. Cantor Fitzgerald analysts commented, "Our rating remains Overweight and our PT remains $80. Although some amount of investor skepticism regarding the company’s growth outlook continues to temper valuation levels, we do not share those concerns. Our long-term DCF model assumptions are mostly conservative, with high single-digit revenue growth and modest margin expansion. Capital spending should moderate in 2019. We think the shares offer a compelling risk/reward trade off (including the potential impact from the VA contract). Valuation Summary Cerner shares trade at a 25% discount to our DCF-based price target of $80 (including the VA contract)." (9/12/2018) 2. According to Zacks Investment Research, "Cerner underperformed its industry in a year's time. Decline in Subscription revenues is discouraging. Lesser-than-expected subscription bookings recently marred Cerner’s licensed software sales. The company has also been grappling with software issues and technology resale. A downbeat guidance is a headwind. Lower margins on technology resale, resulting from higher mix of device resale are a concern. However, the company rides on its solid international growth, which is likely to boost with the company’s prospects in Australia, U.K. Ireland and Germany. We believe that the company has growth opportunities in the revenue cycle management (RCM), Population Health and ambulatory markets based on its product strength and enviable track record of adding new clients. Solid growth in the HealtheIntent platform also holds promise. Further, the company recently reported a suite of developments in its EHR platform." (7/19/2018) 3. Canaccord Genuity analysts commented, "We reiterate our BUY rating and raise our PT to $73. Not without noise on 4Q’17 and updated guidance, CERN continues to perform in new business wins. Bookings performance was stellar, up 62% y/y on large Works wins with solid growth across many product areas. The delayed Veterans Administration signing and some pre-revenue project investment will likely pressure margins near-term, but will be more than offset on the bottom-line from the tax reform benefit. We normally would be more critical on near-term margin compression; however, given bookings strength and benefits from tax reform, we recommend investors continue to own shares and add to positions. Key positive: Bookings grew 62% to $2.3B, outperforming us and cons. both at $1.8B. 1Q’18 bookings guidance straddled our estimate and con." (2/7/2018) Who are some of Cerner's key competitors? Some companies that are related to Cerner include Altaba (AABA), Godaddy (GDDY), Jack Henry & Associates (JKHY), Leidos (LDOS), Open Text (OTEX), CSRA (CSRA), Caci International (CACI), Science Applications International (SAIC), Verint Systems (VRNT), Allscripts Healthcare Solutions (MDRX), Ebix (EBIX), Scientific Games (SGMS), Convergys (CVG), NetScout Systems (NTCT) and Quality Systems (QSII). Who are Cerner's key executives? Cerner's management team includes the folowing people: Mr. Clifford W. Illig, Co-Founder & Vice Chairman (Age 67)Mr. Zane M. Burke, Pres (Age 52)Mr. Marc G. Naughton, Exec. VP & CFO (Age 63)Mr. Michael R. Nill, Exec. VP & COO (Age 53)Mr. Jeffrey A. Townsend, Exec. VP & Chief of Innovation (Age 54) Has Cerner been receiving favorable news coverage? News coverage about CERN stock has trended somewhat positive recently, Accern reports. Accern identifies positive and negative news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cerner earned a media and rumor sentiment score of 0.18 on Accern's scale. They also gave news coverage about the company an impact score of 46.57 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. View Recent Headlines for Cerner. Who are Cerner's major shareholders? Cerner's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.32%), Bank of New York Mellon Corp (4.52%), Parnassus Investments CA (2.17%), Bank of America Corp DE (1.44%), Veritas Asset Management LLP (1.38%) and Northern Trust Corp (1.04%). Company insiders that own Cerner stock include Clifford W Illig, David Brent Shafer, Denis A Cortese, Gerald E Bisbee, Jr, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, Neal L Patterson, Randy D Sims, William D Zollars and Zane M Burke. View Institutional Ownership Trends for Cerner. Which institutional investors are selling Cerner stock? CERN stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, FMR LLC, Bank of New York Mellon Corp, American Century Companies Inc., Sawgrass Asset Management LLC, Renaissance Technologies LLC, Bank of America Corp DE and Scharf Investments LLC. Company insiders that have sold Cerner company stock in the last year include Clifford W Illig, David Brent Shafer, Denis A Cortese, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael R Battaglioli, William D Zollars and Zane M Burke. View Insider Buying and Selling for Cerner. Which institutional investors are buying Cerner stock? CERN stock was purchased by a variety of institutional investors in the last quarter, including Parnassus Investments CA, Epoch Investment Partners Inc., LGT Capital Partners LTD., Veritas Asset Management LLP, BlackRock Inc., Morgan Stanley, Cambiar Investors LLC and Los Angeles Capital Management & Equity Research Inc.. View Insider Buying and Selling for Cerner. How do I buy shares of Cerner? Shares of CERN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Cerner's stock price today? One share of CERN stock can currently be purchased for approximately $63.82. How big of a company is Cerner? Cerner has a market capitalization of $21.05 billion and generates $5.14 billion in revenue each year. The company earns $866.97 million in net income (profit) each year or $2.20 on an earnings per share basis. Cerner employs 26,000 workers across the globe. How can I contact Cerner? Cerner's mailing address is 2800 ROCKCREEK PKWY W0162, NORTH KANSAS CITY MO, 64117. The company can be reached via phone at 816-221-1024 or via email at [email protected] MarketBeat Community Rating for Cerner (NASDAQ CERN)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 824 (Vote Outperform)Underperform Votes: 506 (Vote Underperform)Total Votes: 1,330MarketBeat's community ratings are surveys of what our community members think about Cerner and other stocks. Vote "Outperform" if you believe CERN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/21/2018 by MarketBeat.com StaffFeatured Article: What is the Book Value of a Share?